Bioniche Life Sciences Inc. logo
Exited company

Bioniche Life Sciences Inc.

Industry sector
Investment year
Diversified Portfolio
Learn more
About the company

Bioniche has evolved into a research-based, technology-driven Canadian biopharmaceutical company that discovers, develops, manufactures, and markets proprietary products for human and animal health markets worldwide. Key areas of strategic focus for Bioniche include developing effective therapies for bladder cancer and potentially other cancers; a cattle vaccine to help prevent E. coli O157:H7 infection; and technologies to improve reproduction and potentially replace the use of antibiotics in livestock.

Your privacy

BDC uses cookies to improve your experience on its website and for advertising purposes, to offer you products or services that are relevant to you. By clicking ῝I understand῎ or by continuing to browse this site, you consent to their use.

To find out more, consult our Policy on confidentiality.